4D Molecular Therapeutics Newsroom

Leerink Partners Maintains 4D Molecular Therapeutics(FDMT.US) With Buy Rating, Cuts Target Price to $27

Moomoo News13:31 ET · Ratings

4D Molecular Therapeutics Is Maintained at Outperform by Leerink Partners

Dow Jones11:23 ET · Ratings

Express News | Morgan Stanley Maintains Underweight on 4D Molecular Therapeutics, Lowers Price Target to $6

Benzinga11:15 ET

4D Molecular Downgraded at BMO on Limited Population for Wet AMD Candidate

Seeking AlphaJan 13 09:26 ET

H.C. Wainwright Maintains 4D Molecular Therapeutics(FDMT.US) With Buy Rating, Maintains Target Price $36

Moomoo NewsJan 13 07:34 ET · Ratings

HC Wainwright & Co. Reiterates Buy on 4D Molecular Therapeutics, Maintains $36 Price Target

BenzingaJan 13 07:00 ET · Ratings

Express News | 4D Molecular Therapeutics Inc : Leerink Partners Cuts Target Price to $27 From $31

ReutersJan 13 06:10 ET

Barclays Sticks to Their Buy Rating for 4D Molecular Therapeutics (FDMT)

TipRanksJan 12 08:25 ET · Ratings

BofA Securities Maintains 4D Molecular Therapeutics(FDMT.US) With Buy Rating, Cuts Target Price to $42

Moomoo NewsJan 11 11:31 ET · Ratings

BMO Capital Downgrades 4D Molecular Therapeutics(FDMT.US) to Hold Rating, Cuts Target Price to $15

Moomoo NewsJan 10 18:32 ET · Ratings

Cautious Outlook for 4D Molecular Therapeutics Amid Limited Therapy Durability and Competitive Pressures

TipRanksJan 10 17:55 ET

4D Molecular, FDA Agree on Phase 3 Design for DME Candidate

Seeking AlphaJan 10 11:18 ET

4D Molecular Therapeutics to Focus Pipeline on Wet AMD, Cystic Fibrosis Drug Candidates

MT NewswiresJan 10 08:53 ET

4DMT Extends Cash Runway To 2028 With $506M, Plans Phase 3 Trials For 4FRONT-1 & 4FRONT-2 In Wet AMD, Develops Early-Stage DME And CF, Explores Partnerships And Strategic Financing

BenzingaJan 10 08:03 ET

Express News | 4D Molecular Therapeutics Inc: Cash Runway Extended Under Updated Operating Plan Expected to Fund Operations Into 2028

ReutersJan 10 08:01 ET

Express News | 4D Molecular Therapeutics Inc: Primary Endpoint 52-Week Topline Data for Both 4Front-1 and 4Front-2 Expected in H2 2027

ReutersJan 10 08:01 ET

Express News | 4D Molecular Therapeutics Inc - 4D-150 Well Tolerated With No Intraocular Inflammation Observed

ReutersJan 10 08:01 ET

Express News | 4Dmt Announces Positive Interim Data From 4D-150 Spectra Clinical Trial in Dme and Alignment With FDA on Registrational Path

ReutersJan 10 08:00 ET

4DMT Announces Positive Interim Data From 4D-150 SPECTRA Clinical Trial in DME and Alignment With FDA on Registrational Path

GlobeNewswireJan 10 08:00 ET

Amazon To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Wednesday

BenzingaDec 18, 2024 10:20 ET